HighTower Advisors
ATRA icon

HighTower Advisors’s Atara Biotherapeutics ATRA Stock Holding History

HighTower Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-424
Closed -$42K – 3352
2022
Q3 		$42K Buy
+424
New +$47.6K ﹤0.01% 2902
2021
Q1 		– Sell
-534
Closed -$264K – 3049
2020
Q4 		$264K Buy
+534
New +$246K ﹤0.01% 2016
2020
Q2 		– Sell
-535
Closed -$115K – 2434
2020
Q1 		$115K Buy
+535
New +$170K ﹤0.01% 1918
2019
Q4 		– Sell
-867
Closed -$301K – 2343
2019
Q3 		$301K Buy
867
+99
+13% +$36.9K ﹤0.01% 1786
2019
Q2 		$383K Hold
768
– – ﹤0.01% 1653
2019
Q1 		$768K Sell
768
-20
-3% -$18.6K 0.01% 1257
2018
Q4 		$682K Buy
788
+24
+3% +$22.3K 0.01% 1206
2018
Q3 		$784K Buy
764
+2
+0.3% +$1.96K 0.01% 1240
2018
Q2 		$697K Sell
762
-78
-9% -$83.8K 0.01% 1298
2018
Q1 		$820K Buy
+840
New +$765K 0.01% 1178

Other funds holding ATRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return